Nuran Ercal

Dr. Nuran Ercal


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2010 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
ABAtrayee Banerjee
Atrayee Banerjee
XZXinsheng Zhang
Xinsheng Zhang
KMKalyan Reddy Manda
Kalyan Reddy Manda
WBWilliam A Banks
William A Banks
NENuran Ercal
Nuran Ercal

1 June 2009 in Brain Research
Verified
Journal Article
Closed access
XZXinsheng Zhang
Xinsheng Zhang
ABAtrayee Banerjee
Atrayee Banerjee
WBWilliam A. Banks
William A. Banks
NENuran Ercal
Nuran Ercal

1 April 2011 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
KMKalyan Reddy Manda
Kalyan Reddy Manda
ABAtrayee Banerjee
Atrayee Banerjee
WBWilliam A. Banks
William A. Banks
NENuran Ercal
Nuran Ercal

11 May 2020 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
APAnnalise Pfaff
Annalise Pfaff
JBJustin Beltz
Justin Beltz
EKEmily King
Emily King
NENuran Ercal
Nuran Ercal
The thiol (-SH) functional group is found in a number of drug compounds and confers a unique combination of useful properties. Thiol-containing drugs can reduce radicals and other toxic electrophiles, restore cellular thiol pools, and form stable complexes with heavy metals such as lead, arsenic, and copper. Thus, thiols can treat a variety of conditions by serving as radical scavengers, GSH prodrugs, or metal chelators. Many of the compounds discussed here have been in use for decades, yet continued exploration of their properties has yielded new understanding in recent years, which can be used to optimize their clinical application and provide insights into the development of new treatments. The purpose of this narrative review is to highlight the biochemistry of currently used thiol drugs within the context of developments reported in the last five years. More specifically, this review focuses on thiol drugs that represent the standard of care for their associated conditions, including N-acetylcysteine, 2,3-meso-dimercaptosuccinic acid, British anti-Lewisite, D-penicillamine, amifostine, and others. Reports of novel dosing regimens, delivery strategies, and clinical applications for these compounds were examined with an eye toward emerging approaches to address a wide range of medical conditions in the future.

5 June 2014 in Toxics
Verified
Journal Article
Open access
PDF file
STShakila Tobwala
Shakila Tobwala
HWHsiu-Jen Wang
Hsiu-Jen Wang
JCJoshua Warren Carey
Joshua Warren Carey
WBWilliam A. Banks
William A. Banks
NENuran Ercal
Nuran Ercal
Oxidative stress, which is the loss of balance between antioxidant defense and oxidant production in the cells, is implicated in the molecular mechanism of heavy metal-induced neurotoxicity. Given the key role of lead (Pb) and cadmium (Cd) in inducing oxidative stress, we investigated their role in disrupting the integrity and function of immortalized human brain microvascular endothelial cells (hCMEC/D3). To study this, hCMEC/D3 cells were exposed to control media or to media containing different concentrations of Pb or Cd. Those exposed to Pb or Cd showed significantly higher oxidative stress than the untreated group, as indicated by cell viability, reactive oxygen species (ROS), glutathione (GSH) levels, and catalase enzyme activity. Pb also induced oxidative stress-related disruption of the hCMEC/D3 cell monolayer, as measured by trans-endothelial electrical resistance (TEER), the dextran permeability assay, and the level of tight junction protein, zona occluden protein (ZO-2). However, no significant disruption in the integrity of the endothelial monolayer was seen with cadmium at the concentrations used. Taken together, these results show that Pb and Cd induce cell death and dysfunction in hCMEC/D3 cells and, in the case of Pb, barrier disruption. This suggests blood brain barrier (BBB) dysfunction as a contributing mechanism in Pb and Cd neurotoxicities.

1 January 2016 in Toxicology Letters
Verified
Journal Article
Closed access
AKAhdab Khayyat
Ahdab Khayyat
STShakila Tobwala
Shakila Tobwala
MHMarcia Hart
Marcia Hart
NENuran Ercal
Nuran Ercal